Literature DB >> 27602924

Impact of Preoperative Radiotherapy on Anastomotic Leakage and Stenosis After Rectal Cancer Resection: Post Hoc Analysis of a Randomized Controlled Trial.

Qiyuan Qin1, Tenghui Ma, Yanhong Deng, Jian Zheng, Zhiyang Zhou, Hui Wang, Lei Wang, Jianping Wang.   

Abstract

BACKGROUND: Evidence regarding the effect of preoperative radiotherapy on anastomotic integrity remains conflicting in rectal cancer surgery. Prospective comparisons with appropriate controls are needed.
OBJECTIVE: This study aimed to assess the impact of preoperative radiotherapy on anastomotic leakage and stenosis after rectal cancer resection.
DESIGN: This was a post hoc analysis of a randomized controlled trial (NCT01211210). SETTINGS: Data were retrieved from the leading center of the trial, which is a tertiary hospital. PATIENTS: The full analysis population of 318 patients was included.
INTERVENTIONS: Patients were randomly assigned to receive preoperative radiation (50 Gy per 25 fractions) and 5-fluorouracil infusion, alone (arm A) or combined with oxaliplatin (arm B), or preoperative chemotherapy with 5-fluorouracil and oxaliplatin without radiation (arm C). MAIN OUTCOME MEASURES: The rates of anastomotic leakage and stenosis were calculated for each treatment arm. Multivariate analysis was used to verify the effect of preoperative radiotherapy.
RESULTS: The treatment arms were comparable in terms of most baseline characteristics, but more diversions were used in the chemoradiotherapy arms. Anastomotic leakage occurred in 20.2% of patients in arm A, 23.6% of patients in arm B, and 8.5% of patients in arm C (p = 0.007). The corresponding rates of stenosis were 17.0%, 18.9%, and 6.8% (p = 0.02). Multivariate analysis confirmed the correlation between preoperative radiotherapy and clinical leakage (p = 0.02), which was associated with delayed stenosis (p < 0.001). For patients undergoing chemoradiotherapy, radiation proctitis was identified as an independent risk factor for clinical leakage (p = 0.01) and stenosis (p < 0.001). LIMITATIONS: The main limitations were discrepancies in stoma creation and chemotherapy regimen among the treatment arms.
CONCLUSIONS: Preoperative radiotherapy increases the risk of anastomotic leakage and stenosis after rectal cancer resection. Clinical leakage independently contributes to the development of stenosis.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27602924     DOI: 10.1097/DCR.0000000000000665

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  36 in total

1.  Role of Angiogenesis in Chronic Radiation Proctitis: New Evidence Favoring Inhibition of Angiogenesis Ex Vivo.

Authors:  Peihuang Wu; Li Li; Huaiming Wang; Tenghui Ma; Haiyong Wu; Xinjuan Fan; Zihuan Yang; Daici Chen; Lei Wang
Journal:  Dig Dis Sci       Date:  2017-10-27       Impact factor: 3.199

2.  Preoperative FOLFOX in resectable locally advanced rectal cancer can be a safe and promising strategy: the R-NAC-01 study.

Authors:  Nobuki Ichikawa; Shigenori Homma; Tohru Funakoshi; Masahiro Hattori; Masanori Sato; You Kamiizumi; Kazuyoshi Omori; Masaru Nomura; Ryoichi Yokota; Masahiko Koike; Hirofumi Kon; Keisa Takeda; Hiroyuki Ishizu; Kunihiro Hirose; Daisuke Kuraya; Takahisa Ishikawa; Ryohei Murata; Hiroaki Iijima; Futoshi Kawamata; Tadashi Yoshida; Yosuke Ohno; Nozomi Minagawa; Norihiko Takahashi; Akinobu Taketomi
Journal:  Surg Today       Date:  2019-03-05       Impact factor: 2.549

3.  Anastomotic stricture after ultralow anterior resection or intersphincteric resection for very low-lying rectal cancer.

Authors:  Soo Young Lee; Chang Hyun Kim; Young Jin Kim; Hyeong Rok Kim
Journal:  Surg Endosc       Date:  2017-07-19       Impact factor: 4.584

4.  Pelvic Anastomosis Without Protective Ileostomy is Safe in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.

Authors:  Ekaterina Baron; Vadim Gushchin; Mary Caitlin King; Andrei Nikiforchin; Armando Sardi
Journal:  Ann Surg Oncol       Date:  2020-06-06       Impact factor: 5.344

5.  Late anastomotic leakage after anal sphincter saving surgery for rectal cancer: is it different from early anastomotic leakage?

Authors:  Seung Yoon Yang; Yoon Dae Han; Min Soo Cho; Hyuk Hur; Byung Soh Min; Kang Young Lee; Nam Kyu Kim
Journal:  Int J Colorectal Dis       Date:  2020-05-05       Impact factor: 2.571

6.  Quantitative CT measurement of left colonic and pelvic mesenteric adipose volume in radiation proctitis.

Authors:  Yonghua Cai; Tenghui Ma; Qinghua Zhong; Qiyuan Qin; Wuteng Cao; Zhanzhen Liu; Jia Ke; Hui Wang
Journal:  Ann Transl Med       Date:  2020-07

7.  Smoking cessation for less than 10 years remains a risk factor of anastomotic leakage in mid-to-low rectal cancer patients undergoing sphincter-preserving surgery.

Authors:  Kun-Yu Tsai; Shu-Huan Huang; Jeng-Fu You; Reiping Tang; Jy-Ming Chiang; Chien-Yuh Yeh; Pao-Shiu Hsieh; Wen-Sy Tsai; Sum-Fu Chiang; Cheng-Chou Lai
Journal:  Langenbecks Arch Surg       Date:  2022-01-26       Impact factor: 3.445

8.  Development of a Risk Score to Predict Anastomotic Leak After Left-Sided Colectomy: Which Patients Warrant Diversion?

Authors:  Nicholas P McKenna; Katherine A Bews; Robert R Cima; Cynthia S Crowson; Elizabeth B Habermann
Journal:  J Gastrointest Surg       Date:  2019-06-26       Impact factor: 3.452

Review 9.  Effect of pathological complete response after neoadjuvant chemoradiotherapy on postoperative complications of rectal cancer: a systematic review and meta-analysis.

Authors:  J Yang; W Wang; Y Luo; S Huang; Z Fu
Journal:  Tech Coloproctol       Date:  2022-01-20       Impact factor: 3.781

10.  Risk factors of symptomatic anastomotic leakage and its impacts on a long-term survival after laparoscopic low anterior resection for rectal cancer: a retrospective single-center study.

Authors:  Xinyu Qi; Maoxing Liu; Kai Xu; Pin Gao; Fei Tan; Zhendan Yao; Nan Zhang; Hong Yang; Chenghai Zhang; Jiadi Xing; Ming Cui; Xiangqian Su
Journal:  World J Surg Oncol       Date:  2021-06-25       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.